Quốc gia: Hoa Kỳ
Ngôn ngữ: Tiếng Anh
Nguồn: NLM (National Library of Medicine)
FAMOTIDINE (UNII: 5QZO15J2Z8) (FAMOTIDINE - UNII:5QZO15J2Z8)
Cantrell Drug Company
FAMOTIDINE
FAMOTIDINE 2 mg in 1 mL
INTRAVENOUS
PRESCRIPTION DRUG
unapproved drug other
FAMOTIDINE- FAMOTIDINE INJECTION, SOLUTION CANTRELL DRUG COMPANY _Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been_ _approved by FDA. For further information about unapproved drugs, click here._ ---------- FAMOTIDINE 2 MG/ML IN 0.9% SODIUM CHLORIDE 10 ML SYRINGE FAMOTIDINE famotidine injection, solution PRODUCT INFORMATION PRODUCT T YPE HUMAN PRESCRIPTION DRUG ITE M CODE (SOURCE ) NDC:52533-172 ROUTE OF ADMINISTRATION INTRAVENOUS ACTIVE INGREDIENT/ACTIVE MOIETY INGREDIENT NAME BASIS OF STRENGTH STRE NG TH FAMO TIDINE (UNII: 5QZO15J2Z8 ) (FAMOTIDINE - UNII:5QZO15J2Z8 ) FAMOTIDINE 2 mg in 1 mL Cantrell Drug Company INACTIVE INGREDIENTS INGREDIENT NAME STRE NG TH SO DIUM CHLO RIDE (UNII: 451W47IQ8 X) 9 mg in 1 mL MANNITO L (UNII: 3OWL53L36 A) 4 mg in 1 mL ASPARTIC ACID (UNII: 30 KYC7MIAI) 0 .0 0 5 mg in 1 mL WATER (UNII: 0 59 QF0 KO0 R) OTHER INGREDIENTS INGREDIENT KIND INGREDIENT NAME QUANTITY May co ntain HYDRO CHLO RIC ACID (UNII: QTT1758 2CB) May co ntain SO DIUM HYDRO XIDE (UNII: 55X0 4QC32I) PACKAG ING # ITEM CODE PACKAGE DESCRIPTION MARKETING START DATE MARKETING END DATE 1 NDC:52533-172-12 10 mL in 1 SYRINGE, PLASTIC MARKETING INFORMATION MARKE TING CATE GORY APPLICATION NUMBE R OR MONOGRAPH CITATION MARKE TING START DATE MARKE TING END DATE unappro ved drug o ther 0 6 /11/20 14 LABELER - Cantrell Drug Company (035545763) Revised: 6/2014 Đọc toàn bộ tài liệu